Skip to content

Clinical trials

Pulmonary Fibrosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Country / region: United Kingdom Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20071
20103
20111
20131
20141
20172
20205
20212
20221
20235
20244
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated7
Active, not recruiting6
Recruiting4
Not yet recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Boehringer Ingelheim3
Guy's and St Thomas' NHS Foundation Trust2
Royal Brompton & Harefield NHS Foundation Trust2
Amgen1
Avalyn Pharma Inc.1
Celgene1
Contineum Therapeutics1
Endeavor Biomedicines, Inc.1
Erasmus Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis33
Lung Diseases, Interstitial16
Idiopathic Pulmonary Fibrosis14
Fibrosis4
Idiopathic Interstitial Pneumonias3
COVID-192
Connective Tissue Diseases2
Lung Diseases2
Scleroderma, Diffuse2
Alveolitis, Extrinsic Allergic1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.